IM Cannabis (IMCC) Shares Outstanding (2019 - 2026)
IM Cannabis' (IMCC) quarterly Shares Outstanding (Entity) came in at $4.2 million in Q4 2025, up 91.38% year-on-year from $2.2 million in Q4 2024, and up 19.6% quarter-over-quarter from $3.5 million in Q3 2025.
IM Cannabis (IMCC) Shares Outstanding (2019 - 2026) Analysis & Trends
IM Cannabis' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $4.2 million for Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 91.38% year-over-year to $4.2 million in Q4 2025; TTM through Dec 2025 was $4.2 million, a 91.38% increase from a year earlier, with the FY2025 full-year figure at $4.2 million, up 87.57% from the prior year.
- Shares Outstanding (Entity) climbed to $4.2 million in Q4 2025 per IMCC's latest filing, from $3.5 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $4.2 million in Q4 2025 and bottomed at $625235.5 in Q2 2021.
- The 5-year median for Shares Outstanding (Entity) is $1.6 million (2023), against an average of $1.9 million.
- Across the five-year window, Shares Outstanding (Entity) dropped 1.77% in 2024 and jumped 116.01% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $902013.6 in 2021, then grew by 3.04% to $929434.0 in 2022, then soared by 76.43% to $1.6 million in 2023, then surged by 34.7% to $2.2 million in 2024, then surged by 91.38% to $4.2 million in 2025.
- Per Business Quant, the three latest IMCC Shares Outstanding (Entity) figures stand at $4.2 million (Q4 2025), $3.5 million (Q3 2025), and $2.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 4.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 51.28 Mn |
| Jun 30, 2022 | 51.28 Mn |
| Mar 31, 2022 | 966,069.00 |
| Dec 31, 2021 | 966,069.00 |
| Sep 30, 2021 | 81.68 Mn |
| Jun 30, 2021 | 768,549.00 |